NEW YORK -- The use of some monoclonal antibody treatments against COVID is now being discouraged, and updated guidelines from the NIH COVID Treatment Panel say Regeneron and Eli Lilly's treatments ...

SAN FRANCISCO -- Preliminary data out of South Africa is giving the world insight into how strong omicron really is. The South African Medical Research Council just reported this variant may cause ...

Five regional infusion centers in Texas have run out of sotrovimab, the only COVID-19 monoclonal antibody treatment that appears to be effective against the omicron variant, the Department of Health ...

NEW YORK (WABC) -- With two new pills now authorized by the FDA to fight the effects of COVID, there's a push for New York state to be first in line for the initial shipments. Supplies of Pfizer's ...

When the highly contagious omicron variant of COVID-19 surged in December 2021, filling intensive care units in New Jersey and across the U.S., federal regulators gave emergency authorization to the ...

After Regeneron announced its monoclonal antibody treatment could be less effective against the omicron variant of COVID-19, the state of Texas might eventually be forced to shift its strategy in ...

The US Food and Drug Administration has authorized a new monoclonal antibody treatment that seems to work against the Omicron variant of the virus that causes Covid-19. The US Food and Drug ...

The Food and Drug Administration (FDA) announced Friday that it has issued emergency use authorization (EUA) for Eli Lilly's new monoclonal antibody treatment. Clinical trials have shown the treatment ...